Investments - Additional Information (Detail) - USD ($) $ in Thousands |
1 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Jan. 31, 2022 |
Jun. 30, 2021 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Schedule Of Investments [Line Items] | |||||
| Purchase of available-for-sale securities | $ 10,301 | $ 88,127 | |||
| Prepaid Expenses and Other Current Assets | |||||
| Schedule Of Investments [Line Items] | |||||
| Accrued interest receivable | 500 | $ 700 | |||
| Thirona Bio, Inc. | |||||
| Schedule Of Investments [Line Items] | |||||
| Impairment loss | 6,600 | ||||
| Unrealized gain on investment | $ 1,300 | ||||
| Interest receivable write off | $ 1,100 | ||||
| Convertible Promissory Note | Thirona Bio, Inc. | |||||
| Schedule Of Investments [Line Items] | |||||
| Purchase of available-for-sale securities | $ 5,000 | $ 3,000 | |||
| X | ||||||||||
- Definition Accrued interest receivable. No definition available.
|
| X | ||||||||||
- Definition Interest receivable write off. No definition available.
|
| X | ||||||||||
- Definition Purchase of available-for-sale securities. No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|